Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7795713 | 0.97 | MAPT (0.40) | TTRMAPTL3MBTL1PTPRC | |
| SCHEMBL7792423 | 0.94 | CHRNB4 (0.38) | TTRCHRNB4CHRNA3MAPTL3MBTL1 | |
| SCHEMBL7786141 | 0.93 | MAPT (0.42) | CHRNB4CHRNA3MAPTL3MBTL1KCNA3 | |
| SCHEMBL7792031 | 0.92 | TTR (0.39) | TTRMAPTL3MBTL1PTPRCKCNA3 | |
| SCHEMBL7786024 | 0.91 | MAPT (0.40) | MAPTL3MBTL1KCNA3 | |
| SCHEMBL7792117 | 0.91 | CHRNB4 (0.44) | CHRNB4CHRNA3KCNA3 | |
| SCHEMBL7786049 | 0.90 | MAPT (0.44) | MAPTL3MBTL1KCNA3 | |
| SCHEMBL7786404 | 0.90 | KCNA3 (0.44) | CHRNB4CHRNA3KCNA3 | |
| SCHEMBL7786316 | 0.89 | CHRNB4 (0.42) | TTRCHRNB4CHRNA3KCNA3 | |
| SCHEMBL7791970 | 0.89 | TTR (0.39) | TTRCHRNB4CHRNA3KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0906268-B1 | ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS | AVENTIS PHARMA INC (US) | 2001-11-28 | — | — | EP | disclosed |
| US-6004959-A | HYPOTENSIVE, ANTITUMOR, ANTIINFLAMMATORY AND ANTIASTHMATIC AGENTS; ANGIOGENESIS AND ALVEOLAR MACROPHAGE ACTIVATION INHIBITORS | HOECHST MARION ROUSSEL, INC. (US) | 1999-12-21 | — | — | US | disclosed |